Our Team

Founded in 2013 as a start-up with a small core team, InnoMedica has grown into a pharmaceutical company with its own GMP-certified Nanofactory. An experienced Board of Directors and a cohesive Executive Management team now provide the leadership and expertise necessary to drive the company’s clinical development programs forward.

The InnoMedica team comprises professionals with strong scientific and technical backgrounds. Many team members hold degrees in biochemistry, chemistry, biomedicine or pharmacy — expertise that is essential for advancing our nanocarrier technology and supporting our clinical development activities.

In recruitment, InnoMedica places particular emphasis on motivation, professional competence and opportunities for personal development. Employees are actively supported in their career growth to foster their full potential and contribute to the company’s long-term success.

The Board of Directors of InnoMedica Holding AG, chaired by Dr. Urs Wälchli, ensures efficient decision-making processes and maintains a close connection to the company’s operational activities. With its newly composed Board as of 2025, InnoMedica benefits from expertise across multiple disciplines. The active involvement of Board members in selected projects supports the company’s high execution speed and strategic focus.  

The Executive Management of InnoMedica Schweiz AG includes the founders Dr. Stéfan Halbherr, Andrea Zurkirchen and Pascal Halbherr. The team was further strengthened in 2023 with the appointment of Dr. Martin Stähle.

Together, this leadership team represents continuity, expertise, and a clear strategic focus on the development of innovative therapies.

Member of the Board of Directors

Urs Wälchli

Dr. rer. oec., University of Bern 

Chairman of the Board, Finance, Audit, Compliance

Denis Bron

MD, University of Basel 

Member of the Board of Directors, Vice Chairman, Medicine, Research, Regulatory Affairs

Pascal Brenneisen

 

Member of the Board of Directors, Corporate Development, Partnering

Patrick Hunziker

Prof. Dr. med., University Zurich 

Member of the Board of Directors, Medicine, Research, Regulatory Affairs

Christian Mauriand

 

Member of the Board of Directors, Corporate Development, Partnering

Leila Nobs

Dr., University Geneva  

Member of the Board of Directors, Medicine, Research, Regulatory Affairs

Martin Scholl

 

Member of the Board of Directors, Finance, Audit, Compliance

Management

Stéfan Halbherr

PhD, University of Bern 

General Manager, Head of Research & Development, InnoMedica Holding. Country Manager, InnoMedica Switzerland

Martin Stähle

PhD, University of Hohenheim 

Head of Finance & Administration, InnoMedica Holding and InnoMedica Switzerland

Andrea Zurkirchen

lic. phil., University of Zurich 

Head of Staff Unit, Investor Relations & Legal, InnoMedica Holding. Head of Management Services, InnoMedica Switzerland

Pascal Halbherr

MSc Biochemistry, University of Bern 

Head Manufacturing, InnoMedica Switzerland